The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors
Open accessAbstract
Significance Understanding of myelin diseases and development of new treatment options are at least partly hampered by the limited availability of human oligodendrocytes. Induced pluripotent stem cells (iPSC) may be an ideal tool to circumvent this problem; however, rapid and efficient protocols to generate oligodendrocytes from human iPSC are currently lacking. The induction of the transcription factors SOX10, OLIG2, and NKX6.2 in iPSC-derived neural progenitors accelerates oligodendroglial differentiation significantly resulting in up to 70% of O4 + oligodendrocytes within 28 d. These oligodendrocytes myelinate the CNS during development and after demyelination, and are suitable for pharmacological screens and disease modeling. The strategy presented herein will markedly facilitate the studying of human myelin diseases and the development of screening platforms for drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Somatic sources, such as fibroblasts or peripheral blood cells, can be reprogrammed into iPS cells or directly converted into neural lineages, offering versatile platforms to model MS, PMD and other neuroinflammatory or demyelinating disorders48–55.”
From From insights to innovations: evaluating preclinical paradigms in demyelinating disease therapeutics (2026) · cites this paper as [50]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Oligodendrocytes were derived from iPSCs as previously described [17].”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Lu, Q. R., Yuk, D.-I., Alberta, J., Zhu, Z.-M., Pawlitzky, I., Chan, J., McMahon, A., Stiles, C., & Rowitch, D. H. (2000) · Neuron · doi:10.1016/s0896-6273(00)80897-1 · Cited by 883
Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette
Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., & Mostoslavsky, G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-1075 · Cited by 676
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis
Mei, F., Fancy, S. P. J., Shen, Y. A., Niu, J., Zhao, C., Presley, B., Miao, E., Lee, S., Mayoral, S. R., Redmond, S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3618 · Cited by 595
Wang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., Maherali, N., Studer, L., Hochedlinger, K., Windrem, M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.002 · Cited by 586
A regenerative approach to the treatment of multiple sclerosis
Deshmukh, V. A., Tardif, V., Lyssiotis, C. A., Green, C. C., Kerman, B., Kim, H. J., Padmanabhan, K., Swoboda, J. G., Ahmad, I., Kondo, T., et al. (2013) · Nature · doi:10.1038/nature12647 · Cited by 531
Reinhardt, P., Glatza, M., Hemmer, K., Tsytsyura, Y., Thiel, C. S., Höing, S., Moritz, S., Parga, J. A., Wagner, L., Bruder, J. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059252 · Cited by 461
Self-citationGhetti, B. F., Oblak, A. L., Boeve, B. F., Johnson, K. A., Dickerson, B. C., & Goedert, M. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12213 · Cited by 458
A culture system to study oligodendrocyte myelination processes using engineered nanofibers
Lee, S., Leach, M. K., Redmond, S., Chong, S. Y. C., Mellon, S. H., Tuck, S. J., Feng, Z. Q., Corey, J. M., & Chan, J. R. (2012) · Nature Methods · doi:10.1038/nmeth.2105 · Cited by 455
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
Najm, F. J., Madhavan, M., Zaremba, A., Shick, E., Karl, R. T., Factor, D. C., Miller, T. E., Nevin, Z. S., Kantor, C., Sargent, A., et al. (2015) · Nature · doi:10.1038/nature14335 · Cited by 424
CNS Myelin Sheath Lengths Are an Intrinsic Property of Oligodendrocytes
Bechler, M. E., Byrne, L. M., & ffrench‐Constant, C. (2015) · Current Biology · doi:10.1016/j.cub.2015.07.056 · Cited by 372
Generation of oligodendroglial cells by direct lineage conversion
Yang, N., Zuchero, J. B., Ahlenius, H., Marro, S. G., Ng, Y. H., Vierbuchen, T., Hawkins, J. S., Geissler, R. H., Barres, B. A., & Wernig, M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2564 · Cited by 310
Douvaras, P., Wang, J., Zimmer, M., Hanchuk, S., O’Bara, M. A., Sadiq, S., Sim, F. J., Goldman, J., & Fossati, V. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.06.012 · Cited by 302
Neuroprotection and repair in multiple sclerosis
Franklin, R. J. M., ffrench‐Constant, C., Edgar, J. M., & Smith, K. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.200 · Cited by 285
Najm, F. J., Lager, A. M., Zaremba, A., Wyatt, K., Caprariello, A. V., Factor, D. C., Karl, R. T., Maeda, T., Miller, R. H., & Tesar, P. J. (2013) · Nature Biotechnology · doi:10.1038/nbt.2561 · Cited by 275
Directed differentiation of hippocampal stem/progenitor cells in the adult brain
Jessberger, S., Toni, N., Clemenson, G. D., Ray, J., & Gage, F. H. (2008) · Nature Neuroscience · doi:10.1038/nn.2148 · Cited by 275
Differentiation of human oligodendrocytes from pluripotent stem cells
Hu, B., Du, Z., & Zhang, S. (2009) · Nature Protocols · doi:10.1038/nprot.2009.186 · Cited by 260
Warlich, E., Kuehle, J., Cantz, T., Brugman, M. H., Maetzig, T., Galla, M., Filipczyk, A. A., Halle, S., Klump, H., Schöler, H. R., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.314 · Cited by 259
Self-citationProgramming human pluripotent stem cells into white and brown adipocytes
Ahfeldt, T., Schinzel, R. T., Lee, Y., Hendrickson, D. G., Kaplan, A. N., Lum, D. H., Camahort, R., Xia, F., Shay, J., Rhee, E. P., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2411 · Cited by 256
Klein, C., Krämer, E.-M., Cardine, A.-M., Schraven, B., Brandt, R., & Trotter, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00698.2002 · Cited by 250
Liu, Z., Hu, X., Cai, J., Liu, B., Peng, X., Wegner, M., & Qiu, M. S. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.10.007 · Cited by 217
Piao, J., Major, T., Auyeung, G., Policarpio, E., Menon, J., Droms, L. A., Gutin, P. H., Uryu, K., Tchieu, J. H., Soulet, D., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.01.004 · Cited by 196
Lachapelle, F., Gumpel, M., Baulac, M., Jacque, C., Duc, P., & Baumann, N. (2007) · Developmental Neuroscience · doi:10.1159/000112359 · Cited by 192
Glial Progenitor Cell–Based Treatment and Modeling of Neurological Disease
Goldman, S. A., Nedergaard, M., & Windrem, M. S. (2012) · Science · doi:10.1126/science.1218071 · Cited by 180
Tallantyre, E. C., Bø, L., Alrawashdeh, O., Owens, T., Polman, C. H., Lowe, J. S., & Evangelou, N. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510364992 · Cited by 180
Izrael, M., Zhang, P., Kaufman, R., Shinder, V., Ella, R., Amit, M., Itskovitz‐Eldor, J., Chebath, J., & Revel, M. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.11.008 · Cited by 178
Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer’s disease
Goedert, M., & Spillantini, M. G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00037-5 · Cited by 175
Amyotrophic lateral sclerosis: Problems and prospects
Sreedharan, J., & Brown, R. H. (2013) · Annals of Neurology · doi:10.1002/ana.24012 · Cited by 143
Differentiation of induced pluripotent stem cells into functional oligodendrocytes
Czepiel, M., Balasubramaniyan, V., Schaafsma, W., Stančić, M., Mikkers, H., Huisman, C., Boddeke, E., & Copray, S. (2011) · Glia · doi:10.1002/glia.21159 · Cited by 134
Pozniak, C., Langseth, A. J., Dijkgraaf, G. J., Choe, Y., Werb, Z., & Pleasure, S. (2010) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1016485107 · Cited by 133
Kovács, G. G., Majtényi, K., Spina, S., Murrell, J. R., Gelpí, E., Höftberger, R., Fraser, G. M., Crowther, R. A., Goedert, M., Budka, H., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318187a80f · Cited by 130
Ascl1 is required for oligodendrocyte development in the spinal cord
Sugimori, M., Nagao, M., Parras, C., Nakatani, H., Lebel, M., Guillemot, F., & Nakafuku, M. (2008) · Development · doi:10.1242/dev.015370 · Cited by 116
Hallmann, A.-L., Araúzo-Bravo, M. J., Mavrommatis, L., Ehrlich, M., Röpke, A., Brockhaus, J., Missler, M., Sterneckert, J. L., Schöler, H. R., Kuhlmann, T., et al. (2017) · Scientific Reports · doi:10.1038/srep42991 · Cited by 103
Self-citationEhrlich, M., Hallmann, A.-L., Reinhardt, P., Araúzo-Bravo, M. J., Korr, S., Röpke, A., Psathaki, O. E., Ehling, P., Meuth, S. G., Oblak, A. L., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.06.001 · Cited by 94
Self-citationStacpoole, S., Spitzer, S. O., Bilican, B., Compston, A., Káradóttir, R. T., Chandran, S., & Franklin, R. J. M. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.09.006 · Cited by 91
Lam, B. Y. K., Halliday, G. M., Irish, M., Hodges, J. R., & Piguet, O. (2014) · Human Brain Mapping · doi:10.1002/hbm.22420 · Cited by 90
Seiberlich, V., Bauer, N. G., Schwarz, L., Ffrench‐Constant, C., Goldbaum, O., & Richter‐Landsberg, C. (2015) · Glia · doi:10.1002/glia.22832 · Cited by 84
Developmental changes of tau protein and mRNA in cultured rat brain oligodendrocytes
Gorath, M., Stahnke, T., Mronga, T., Goldbaum, O., & Richter‐Landsberg, C. (2001) · Glia · doi:10.1002/glia.1098 · Cited by 81
Transcription factor induction of human oligodendrocyte progenitor fate and differentiation
Wang, J., Pol, S. U., Haberman, A. K., Wang, C., O’Bara, M. A., & Sim, F. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408295111 · Cited by 79
Gansmüller, A., Lachapelle, F., Evercooren, A. B., Hauw, J., Baumann, N., & Gumpel, M. (1987) · Developmental Neuroscience · doi:10.1159/000112253 · Cited by 68
Kim, J. B., Lee, H.-A., Araúzo-Bravo, M. J., Hwang, K., Nam, D., Park, M. R., Zaehres, H., Park, K. I., & Lee, S. (2015) · The EMBO Journal · doi:10.15252/embj.201592652 · Cited by 52
Self-citationBuchet, D., Garcia, C. I., Deboux, C., Nait‐Oumesmar, B., & Evercooren, A. B. (2011) · Brain · doi:10.1093/brain/awr030 · Cited by 52
Response of Human Oligodendrocyte Progenitors to Growth Factors and Axon Signals
Cui, Q., Fragoso, G., Miron, V. E., Darlington, P. J., Mushynski, W. E., Antel, J. P., & Almazán, G. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ef3be4 · Cited by 50
Self-citationAtkins, H. L., & Freedman, M. S. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-931-4_16 · Cited by 43
Maire, C. L., Buchet, D., Kerninon, C., Deboux, C., Evercooren, A. B., & Nait‐Oumesmar, B. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22194 · Cited by 43
Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination
Preisner, A., Albrecht, S., Cui, Q., Hucke, S., Ghelman, J., Hartmann, C., Taketo, M. M., Antel, J. P., Klotz, L., & Kuhlmann, T. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1426-z · Cited by 41
Self-citationLu, P. H., Lee, G. J., Shapira, J. S., Jimenez, E. E., Mather, M. J., Thompson, P. M., Bartzokis, G., & Mendez, M. F. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131481 · Cited by 41
Skin-derived neural precursors competitively generate functional myelin in adult demyelinated mice
Mozafari, S., Laterza, C., Roussel, D., Bachelin, C., Marteyn, A., Deboux, C., Martino, G., & Evercooren, A. B. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80437 · Cited by 38
Self-citationMarteyn, A., Sarrazin, N., Yan, J., Bachelin, C., Deboux, C., Santin, M. D., Gressens, P., Zujovic, V., & Baron-Van Evercooren, A. (2016) · Stem Cells · doi:10.1002/stem.2263 · Cited by 38
Self-citationLopresti, P. (2002) · Glia · doi:10.1002/glia.10035 · Cited by 33
Inoue, Y., Inoue, K., Terashima, T., Mikoshiba, K., & Tsukada, Y. (1983) · Anatomy and Embryology · doi:10.1007/bf00315814 · Cited by 22
Flagged first, then by citations
Cited by
Sorted by citations
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes‐Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 799
Oligodendrocytes in development, myelin generation and beyond
Kuhn, S., Gritti, L., Crooks, D., & Dombrowski, Y. (2019) · Cells · doi:10.3390/cells8111424 · Cited by 625
Modeling Alzheimer’s disease with iPSC-derived brain cells
Penney, J., Ralvenius, W. T., & Tsai, L.-H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0468-3 · Cited by 471
In vitro Models of Neurodegenerative Diseases
Slanzi, A., Iannoto, G., Rossi, B., Zenaro, E., & Constantin, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00328 · Cited by 313
Fard, M. K., van der Meer, F., Sánchez, P., Cantuti-Castelvetri, L., Mandad, S., Jäkel, S., Fornasiero, E. F., Schmitt, S., Ehrlich, M., Starost, L., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7816 · Cited by 249
“To extend the analysis to human cells, we generated oligodendrocytes from induced pluripotent human stem cells (iPSCs) derived from healthy human adults (29).”
BackgroundSelf-citation
Metadata
- Authors
- Ehrlich, M., Mozafari, S., Glatza, M., Starost, L., Velychko, S., Hallmann, A.-L., Cui, Q.-L., Schambach, A., Kim, K.-P., Bachelin, C., Marteyn, A., Hargus, G., Johnson, R. M., Antel, J., Sterneckert, J., Zaehres, H., Schöler, H. R., Baron-Van Evercooren, A., & Kuhlmann, T.
- Affiliations
- University Hospital Münster (DE)
- Centre National de la Recherche Scientifique (FR)
- Max Planck Institute for Molecular Biomedicine (DE)
- Montreal Neurological Institute and Hospital (CA)
- Medizinische Hochschule Hannover (DE)
- McGill University (CA)
- Center for Regenerative Therapies Dresden (DE)
- University of Münster (DE)
- INSERM, U1127, F-75013 Paris, France;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-02-28
- Volume
- 114
- Issue
- 11
- Pages
- E2243-E2252
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5358375
- OpenAlex
- W2592644893
- Cited by
- 257
- References
- 51
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 26 · 2023: 25 · 2022: 39 · 2021: 28 · 2020: 35 · 2019: 31 · 2018: 19 · 2017: 5
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-11-INBS-0011)
- National Institute of Neurological Disorders and Stroke (R25NS070697)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- oligodendrocyte differentiation, induced pluripotent stem cells, transcription factors, SOX10, Olig2, NKX6-2, myelination, myelin diseases, demyelination, neural progenitor cells, disease modeling, drug discovery screening
- MeSH terms
- Ectopic Gene Expression, Animals, Brain, Cell Differentiation, Cells, Cultured, Demyelinating Diseases, Disease Models, Animal, Myelin Basic Protein, Humans, Mutation, Myelin Sheath, Oligodendroglia, Spinal Cord, Transcription Factors, Biomarkers, Cluster Analysis, tau Proteins, Cell Death, Oxidative Stress, Cell Lineage, Gene Expression Profiling, Mice, Induced Pluripotent Stem Cells, Neural Stem Cells, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
